Our Journals
Feature
Protecting the NHS for future generations—services only for the poor are poor services
As the UK Government faces increasing opposition to its Health and Social Care Bill, read a passionate Essay in defence of democracy and the National Health Service by Professor John R Ashton, CBE, a highly respected public health leader in Britain who was for 13 years the Regional Director of Public Health and Regional Medical Officer for the North West in the UK. Ashton warns that "At a time when the NHS has never been more popular and when there is increasing evidence of its cost-effectiveness, we are sleep-walking into its destruction."
|
Selected Online First articles from The Lancet journals ahead of print publication.
|
Endometriosis and ovarian cancer
Article The Lancet Oncology (online February 22)
|
|
Alcohol-related deaths in England and Wales
Comment The Lancet (online February 20)
|
|
Health inequalities in New Zealand
Article The Lancet (online February 20)
|
-
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trialArticle The Lancet (online February 23)
-
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trialArticle The Lancet (online February 21)
-
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 studyArticle The Lancet Oncology (online February 21)
-
Hepatocellular carcinomaSeminar The Lancet (online February 20)
-
UN Envoy's response to estimates of global malaria mortalityCorrespondence The Lancet (online February 17)
-
Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic reviewReview The Lancet Infectious Diseases (online February 17)
The Lancet's summary of
news and developments across medicine
This Week in Medicine represents a snapshot of important, interesting, and sometimes quirky health-related happenings from around the world reported in the past week or so.
This up-to-date content is free to all our users.
Making the most of evaluation
Papers published on The Lancet UK Policy Matters microsite raise concerns about the quality of past evaluations commissioned directly or indirectly by the Department of Health. Read the papers and accompanying blog post to find out more.
About UK Policy Matters
UK Policy Matters is a Lancet-based project which explores how UK policy changes affect health. On our microsite you will be able to access evidence-based summaries of different policies and tell us your experiences of how changes in policy have affected health.
How can you help?
If you have evidence of how policy has affected health or health care, we would like to hear from you. We are interested in all forms of evidence, including brief summaries of evidence from academics; and information from the public, managers, and healthcare workers about changes in services and their impact (individual experiences are welcomed).
See the Submit your evidence section of the site to share your experiences and submit your evidence.
Most read in The Lancet journals in January 2012
| 1. |
Eye can see a nest of worms!
Clinical Picture
(2012)
The Lancet
Online First
|
| 2. |
Global health in 2012: development to sustainability
Editorial
(2012)
The Lancet
379
(9812), pp.
193
|
| 3. |
Health effects of financial crisis: omens of a Greek tragedy
Correspondence
(2011)
The Lancet
378
(9801), pp.
1457-1458
|
| 4. |
Anticoagulant loses its lustre
World Report
(2012)
The Lancet
379
(9813), pp.
301
|
| 5. |
The Research Works Act: a damaging threat to science
Editorial
(2012)
The Lancet
379
(9813), pp.
288
|
Most cited in The Lancet since 1996
| 1. | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Research (1998) Lancet 352 (9131), pp. 837-853
|
| 2. | MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
Research (2002) Lancet 360 (9326), pp. 7-22
|
| 3. | Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Research (1998) Lancet 351 (9118), pp. 1755-1762
|
| 4. | Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
Research (2001) Lancet 358 (9286), pp. 958-965
|
| 5. | A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
Research (1996) Lancet 348 (9038), pp. 1329-1339
|
|
Join The Lancet Student for free content |
|
Find us on Facebook |
|
Follow us on Twitter |
AnnouncementsGlobal Health Lab: ECOHOST and The Lancet present Are conspiracy theories the greatest threat to global health? Feb 28, 2012 at the LSHTM. Latest Clinical Video: homozygous familial hypercholesterolaemia The Lancet Middle East Editorial Page: breast cancer in the Middle East. |
A 32-year-old man presented to the emergency department with 1-month history of continuous chest pain, which was worse with movement and on application of pressure to the anterior chest wall. Physical examination showed a pustule on the sole of his left foot and multiple pustules on his palms. Blood analysis, chest radiography, and ECG results were normal.
View Clinical Picture
Letter to the Editor
"Although we agree that a critical look at the possible overuse of surgery in...high-income countries is warranted, we strongly advocate that more resources be placed into addressing the surgical needs of populations in the developing world."
Listen to summaries of The Lancet journals in mp3 format
Latest video highlights from the At the Limits events
Cardiology & Diabetes at the Limits
The "Code of Practice" - when will the limits be reached?
Nephrology at the Limits
Consequences of HIV infection in South Africa
Oncology at the Limits
Lessons from acute myeloid leukaemia
